ScripsAmerica Reports March Revenue of Over $494,000 for Its Managed Specialty Pharmacy
April 01 2014 - 7:30AM
ScripsAmerica, Inc. (OTCBB:SCRC) today announced
that the specialty pharmacy it recently entered into a management
agreement with recorded $494,643 in prescription sales for the
month of March. The pharmacy has generated a total of $642,267 in
revenue over the last six weeks since ScripsAmerica entered an
agreement to manage its operations in exchange for a significant
percentage of its revenues. March's revenues give the pharmacy an
annual run rate of $5.94 million. "ScripsAmerica is very pleased to
report that our new specialty pharmacy generated very strong
revenues in March and we anticipate its monthly prescription sales
to experience steady growth. This represents a new and consistent
monthly revenue stream that will increase Scrips' shareholder value
in addition to our pharmaceutical distribution equity ventures and
sales of RapiMed," commented ScripsAmerica's CEO, Bob
Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and
nutraceutical drugs, delivering pharmaceutical products to a wide
range of end users across the health care industry. End users
include retail pharmacies, hospitals, long-term care facilities and
government and home care agencies. For more information, visit
www.ScripsAmerica.com.
Safe Harbor Statement This release includes
forward-looking statements, which are based on certain assumptions
and reflects management's current expectations. These
forward-looking statements are subject to a number of risks and
uncertainties that could cause actual results or events to differ
materially from current expectations. Some of these factors
include: general global economic conditions; general industry and
market conditions, sector changes and growth rates; uncertainty as
to whether our strategies and business plans will yield the
expected benefits; increasing competition; availability and cost of
capital; the ability to identify and develop and achieve commercial
success; the level of expenditures necessary to maintain and
improve the quality of services; changes in the economy; changes in
laws and regulations, including codes and standards, intellectual
property rights, and tax matters; or other matters not anticipated;
our ability to secure and maintain strategic relationships and
distribution agreements. The Company disclaims any intention or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or
otherwise.
CONTACT: 888-959-7095
ir@sealpointconsulting.com
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From Apr 2024 to May 2024
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about ScripsAmerica Inc (CE) (OTCMarkets): 0 recent articles
More News Articles